Healthcare Finance News September 25, 2018
While a majority of patients say they would consider the technologies to diagnose cancer and recommend treatment, they still fear costs.
WHAT HAPPENED
A new survey from McKesson and Ipsos revealed widespread openness toward AI and genetic testing as a solution for cancer diagnosis, but concern about cost is pervasive and could actually steer patients away from any treatment at all.
WHY IT MATTERS
According to information from the World Health Organization cited by McKesson, it is predicted that nearly 10 million people will die of cancer this year and more than 18 million new cases will be diagnosed around the world. Of the 2,012 adults Ipsos surveyed, 62 percent expressed concern about whether they could afford cancer treatment...